Drugs / TAK-137
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02322606 | Nov 2014 → May 2015 | — | Takeda | Withdrawn | No outcome recorded |
| Phase 1 | NCT02163915 | Jun → Nov 2014 | attention deficit-hyperactivity disorder | Takeda | Terminated | No outcome recorded |
| Phase 1 | NCT02334982 | Jun 2013 → Jan 2014 | — | Takeda | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TAK-137 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02322606 ↗ |
| Route | Oral | “multiple oral doses” NCT02163915 ↗ |